Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 7Cancer Pain 4Uterine Cervical Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Postoperative Complications 1Ovarian Neoplasms 1Neuralgia 1Neoplasms 1Malignant Female Reproductive System Neoplasm 1Lymphoma, Follicular 1Intraoperative Complications 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Emergencies 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Acute Pain 1

Interventions

Therapeutics 1Mental Status and Dementia Tests 1Laparotomy 1Hydromorphone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Malignant Female Reproductive System Neoplasm × Hydromorphone × Clear all
NCT04258631 2024-10-16

Liposomal Bupivacaine With or Without Hydromorphone for the Improvement of Pain Control After Laparotomy in Patients With Gynecological Malignancies

Mayo Clinic

Phase 4 Completed
105 enrolled 22 charts

Malignant Female Reproductive System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡